@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix go: . @prefix Protein: . @prefix rgd: . @prefix geneProductOf: . @prefix hasAgent: . @prefix species: . @prefix occursIn: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0003824 . sub:_2 geneProductOf: rgd:61897; a Protein: . sub:_3 occursIn: species:10116; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject schem:Platelet%20activating%20factor%20phosphatidate; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"Platelet activating factor phosphatidate\") -> cat(p(RGD:Ptafr))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_4 dce:identifier "Pfe2 and Pfe3 old report"; dce:title "Pfe2 and Pfe3 old report"; dce:type "Other" . sub:_5 prov:value "Treatment of HL-60 cells with phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, or dibutyryl-cyclic AMP (dbcAMP), a protein kinase A (PKA) activator, resulted in a 90% decrease in the level of TfR mRNA"; prov:wasQuotedFrom sub:_4 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource sub:_4; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:45.578+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }